Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) has issued an announcement.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited held its Annual General Meeting for the financial year ending December 31, 2024, on May 15, 2025. The meeting was conducted both in-person in Tianjin, China, and via video conferencing in Singapore, allowing participation from both A-Share and S-Share shareholders. The AGM was chaired by Ms. Wang Lei, and voting was conducted through a combination of on-site and online methods. This meeting underscores the company’s commitment to engaging with its shareholders across different regions, reflecting its operational transparency and adaptability.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
See more insights into 2TZ stock on TipRanks’ Stock Analysis page.